Skip to main content
Teresa Tarrant, MD, Rheumatology, Durham, NC, Duke University Hospital

TeresaKTarrantMDFAAAAI

Rheumatology Durham, NC

Rheumatoid Arthritis & Related

Associate Professor and Vice Chief of Translational Research, Division of Rheumatology and Immunology, Duke University

Dr. Tarrant is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tarrant's full profile

Already have an account?

Summary

  • I am a Clinical Immunologist board certified in Allergy Immunology and Rheumatology, and I specialize in diseases of and related to Rheumatoid arthritis, Sjogren's syndrome, Inflammatory Eye disease, CVID, and Immunodeficiency in Aging.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Allergy and Immunology, 2001 - 2005
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1999 - 2001
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 1999

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1999 - 2025
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Board of Directors Rheumatology Research Foundation
  • Scientific Advisory Committee Rheumatology Research Foundation
  • Academic Career Leadership Academy in Medicine (ACCLAIM) University of North Carolina, 2014-2015
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • FDA Approves First Drug for WHIM Syndrome
    FDA Approves First Drug for WHIM SyndromeApril 30th, 2024
  • Accuracy in Rheumatoid Arthritis Testing Can Improve Diagnosis, Lower Costs
    Accuracy in Rheumatoid Arthritis Testing Can Improve Diagnosis, Lower CostsSeptember 11th, 2020
  • Researchers Focusing on Protein Interactions with Optineurin as Possible Paget’s Bone Disease Treatment
    Researchers Focusing on Protein Interactions with Optineurin as Possible Paget’s Bone Disease TreatmentSeptember 11th, 2020
  • Join now to see all

Grant Support

  • A New Technology for Targeted Delivery of Anti-Inflammatory AgentsUniversity of North Carolina2015–Present
  • G18 regulates autoimmune pathophysiology in arthritis.Rheumatology Research Foundation2014–Present
  • Interrogating genetic susceptibility loci in CVID with autoimmunityUCSF and Primary Immune Deficiency Treatment Consortium (PIDTC)2015
  • Validating GPSM3 as a key regulator of monocyte-driven inflammatory arthritisRheumatology Research Foundation Disease Targeted Research Initiative2012–2014
  • G Protein-Coupled Receptor Kinase 3 Regulation Of Leukocyte Function In InflammatNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
  • G Protein Coupled Receptor Regulatory Mechanisms In ArthritisNational Institute Of Allergy And Infectious Diseases2006–2010

Committees

  • Board of Directors, Rheumatology Research Foundation 2016 - Present
  • Basic Science Subcommittee, American College of Rheumatology Annual Meeting Planning Committee 2015 - Present
  • Primary Immunodeficiency Diseases Committee, Basic Clinical Immunology Interest Group of the American Academy of Allergy, Asthma, and Immunology 2015 - Present

Professional Memberships

Hospital Affiliations